Nationwide Children's Research News

Aug 18, 2016

Study Finds Average of Two Injuries Every Hour in the U.S. from Strollers and Carriers

Although strollers and carriers are typically used to safely transport children, injuries do occur while using these products. A study conducted by the Center for Injury Research and Policy of the Research Institute at Nationwide Children’s Hospital found that, over a 21-year period from 1990

AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
Jul 20, 2016

AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

AveXis, Inc., (Nasdaq:AVXS) a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced the U.S.

May 09, 2016

New Study Finds Child E-Cigarette Exposures up 1,500%

As the household presence of e-cigarettes and liquid nicotine has increased, so have exposures among young children. A new study conducted by the Center for Injury Research and Policy of the Research Institute and the Central Ohio Poison Center, both at Nationwide Children’s Hospital, found

Apr 28, 2016

First Implantable Hemodynamic Monitoring Device in Single Ventricle Fontan Anatomy

While the Fontan procedure has improved the short- and mid-term outcomes for patients born with single ventricle anatomy, long-term complications of Fontan circulation include heart failure.

Apr 27, 2016

Despite Safety Concerns, Nearly 1 in 4 Babies in NICUs Receive Acid Suppressing Medication Originally Formulated for Older Children, Adults

Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death.

Apr 26, 2016

Biosortia Pharmaceuticals Announces Three New Oncology Research Projects Using Microalgal Compounds

Biosortia Pharmaceuticals has launched three new oncology research projects. The projects will investigate Biosortia’s unique libraries of consortia microbial compounds for potential drug discovery in pediatric cancer (neuroblastoma), liver cancer (Hepatitis C virus) and an alternative

Apr 08, 2016

New Study Finds Skateboarding Sent About 176 Youth to U.S. EDs Every Day

Skateboarding is a popular recreational sport and participation has increased the last several decades, faster than any other sport or recreation activity between 1998 and 2007.* With growing participation, has come an increasing rate of injuries from skateboarding.

Apr 07, 2016

Often Unreported, a Gray Matter Abnormality Predicts Neurodevelopmental Problems in Smaller Premature Babies

Magnetic resonance imaging of the brain is increasingly used to predict neurodevelopmental outcomes in premature infants, but the existing systems of analyzing or “scoring” those MRIs rely heavily on expert opinion.

Feb 29, 2016

Loss of MHCI in Motor Neurons Leads to ALS Astrocyte Toxicity

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating progressive neurodegenerative disease that results in the death of motor neurons, the nerve cells that control muscles.

Feb 18, 2016

Novel Approach Obtains Protein Signatures from Host and Pathogen With One Small Sample

A novel study from researchers at Nationwide Children's Hospital has shown that it is possible to obtain both host and bacteria protein signatures in a sample smaller than the average human biopsy.